Karin Knobe (Former)

1 – 10 of 26

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/5713ffc4-59d2-4651-a7cb-4a227ce2beb8?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2018
Mark Evaluation of prophylactic therapy in haemophilia with global coagulation tests
Zetterberg, E. ^LU ; Brolin, K. ; Lindahl, R. ; Knobe, K. ^LU and Berntorp, E. ^LU (2018) In Haemophilia 24(1). p.10-13
- Contribution to journal › Letter
2017
Mark Comparative burden of arthropathy in mild haemophilia : a register-based study in Sweden
Osooli, M ^LU ; Lövdahl, S ^LU ; Steen Carlsson, K ^LU ; Knobe, K ^LU ; Baghaei, F. ; Holmström, M ; Astermark, J ^LU and Berntorp, E ^LU (2017) In Haemophilia 23(2). p.79-86
- Contribution to journal › Article
2012
Mark Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
Knobe, Karin ^LU ; Tedgård, Ulf ^LU ; Ek, Torben ; Sandström, Per-Erik and Hillarp, Andreas ^LU (2012) In European Journal of Pediatrics 171(9). p.1383-1387
- Contribution to journal › Article
Mark Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
Halldén, Christer ^LU ; Knobe, Karin ^LU ; Sjörin, Elsy ^LU ; Nilsson, David ^LU and Ljung, Rolf ^LU (2012) In Haemophilia 18(3). p.132-137
- Contribution to journal › Article
Mark How to manage invasive procedures in children with haemophilia.
Ljung, Rolf ^LU and Knobe, Karin ^LU (2012) In British Journal of Haematology 157(5). p.519-528
- Contribution to journal › Article
Mark Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
Collins, P W ; Møss, J ; Knobe, Karin ^LU ; Groth, A ; Colberg, T and Watson, E (2012) In Journal of Thrombosis and Haemostasis 10(11). p.2305-2312
- Contribution to journal › Article
Mark New treatments in hemophilia: insights for the clinician.
Knobe, Karin ^LU and Berntorp, Erik ^LU (2012) In Therapeutic advances in hematology 3(3). p.165-175
- Contribution to journal › Article
2011
Mark Joint protection in haemophilia
Rodriguez-Merchan, E. C. ; Jimenez-Yuste, V. ; Aznar, J. A. ; Hedner, Ulla ^LU ; Knobe, Karin ^LU ; Lee, C. A. ; Ljung, Rolf ^LU ; Querol, F. ; Santagostino, E. and Valentino, L. A. , et al. (2011) In Haemophilia 17. p.1-23
- Contribution to journal › Article
Mark Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
Negrier, Claude ; Knobe, Karin ^LU ; Tiede, Andreas ; Giangrande, Paul and Moss, Judi (2011) In Blood 118(10). p.2695-2701
- Contribution to journal › Article
Mark Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
Ostergaard, Henrik ; Bjelke, Jais R. ; Hansen, Lene ; Petersen, Lars Christian ; Pedersen, Anette A. ; Elm, Torben ; Moller, Flemming ; Hermit, Mette B. ; Holm, Pernille K. and Krogh, Thomas N. , et al. (2011) In Blood 118(8). p.2333-2341
- Contribution to journal › Article

« previous
1
2
3
next »